https://www.selleckchem.com/ph....armacological_epigen
0873). Among 263 patients with second-line therapy, bismuth quadruple therapy showed significantly higher eradication rate than quinolone-based triple therapy (73.9% vs. 51.5% in ITT analysis, p=.001; 82.7% vs. 63.0% in PP analysis, p=.002). Concomitant therapy is the best regimen for the first-line H.pylori eradication showing consistently higher eradication rate with an increasing trend for the last 10years in Korea. Bismuth quadruple therapy should be considered for second-line therapy after eradication failure using non-b
Like
Comment
Share
